Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Quarter Shows Company’s Continued Strong Financial Position and Momentum with its MS Clinical Trials and unbuzzdTM Recreational Beverage and Alcohol Metabolizer Quarter Shows Company’s Continued Strong Financial Position and Momentum with its MS Clinical Trials and unbuzzdTM Recreational Beverage and Alcohol Metabolizer